Pharma | pharmaphorum

Skip to main content

Friday 26 December 2025

BlueSky linkedin youtube

header links

Get Newsletters
Media Kit

Pharmaphorum menu first category

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
Spotlight on
Events

close

SECTION

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

Channels

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

SUB NAVIGATION

Live Coverage
Partner Content
About us
Work for us
Contribute
Contact us
Advertise

Newsletters and Deep Dive digital magazine

youtube linkedin BlueSky

Pharma

White Papers

Com_Out_IMG_840x470

Sponsored

Seizing the potential of commercial outsourcing in the pharm...

The power and potential of outsourcing has long been recognised as a core enabler of business growth.

Views & Analysis

deep_dive_slider images_digital health pharmaslayer article

Digital health: pharma slayer or shot in the arm?

Traditional healthcare is facing unprecedented transformation, with patients and technology forcing change.

Views & Analysis

deep_dive_slider images_dive in the waters fine

Come on, dive in, the water's fine!

Top tips for ‘digitally cautious’ pharma.

Events

cts-468x80

Partner Content

Clinical Trial Supply Southeast Conference 2017

Clinical Trial Supply Southeast

Partner Content

Skin and Blister Founders_Katie and Fiona

Partner Content

Skin and Blister Agency, launch on a mission

Skin and Blister, launch and mission announcement

Views & Analysis

deep_dive_slider images_gamification article

The art of gamification

Games have the power to make people happy and benefit health.

Load more results

Editor's Picks

US BIOSECURE Act passed by Congress

Lilly points to long-lasting weight loss with orforglipron

As year-end nears, pharma groups plump up their pipelines

CDC signs off on advice ending universal hepatitis B jabs

Enhertu moves into frontline breast cancer treatment

News

CMS aims for broader GLP-1 access via federal programmes

CMS aims for broader GLP-1 access via federal programmes

CMS has revealed a new, voluntary access programme that aims to broaden the use of GLP-1 agonist medicines for diabetes and obesity.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Physicians walking and using tablet devices

Sponsored

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.

Pharmaphorum Menu

Digital
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Market Access
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Oncology
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Patients
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
R&D
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Sales & Marketing
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Spotlight on

Sign up for email newsletters and Deep Dive

Get Newsletters

youtube linkedin BlueSky

About us Advertising Contact us

Contribute Cookie Policy Privacy Policy

Terms & Conditions Work for us

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2025, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2025, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company